• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌中p53、增殖细胞核抗原与c-erbB-2表达之间的相互关系

Interrelationship between expression of p53, proliferating cell nuclear antigen and c-erbB-2 in bladder cancer.

作者信息

Lipponen P K

机构信息

Department of Pathology, University of Kuopio, Finland.

出版信息

Pathobiology. 1993;61(3-4):178-82. doi: 10.1159/000163788.

DOI:10.1159/000163788
PMID:8105802
Abstract

The expression of c-erbB-2, p53 and proliferating cell nuclear antigen (PCNA) was studied using immunocytochemical techniques in paraffin-embedded biopsy specimens (consecutive 5-microns sections) from 104 transitional cell bladder tumours. 46/104 (44%) of the tumours were positive for c-erbB-2, 29/104 (28%) for p53 and 88/104 (85%) for PCNA. The expression of these antigens was independent of T-category, whereas the expression was significantly related to histological differentiation and papillary status so that non-papillary high-grade tumours were usually positive for all the antigens. The expression of c-erbB-2 and p53 was intense in 8/104 (8%) of cases and weak or absent in 76/104 (73%) of cases (p = 0.0003). The expression of p53 and PCNA was intense in 22/104 (21%) and weak or absent in 76/104 (73%) of tumours (p = 0.0003). Intense expression of c-erbB-2 and PCNA was also interrelated significantly (p = 0.0202). All three antigens were simultaneously expressed in 16-29% of T2-T4 tumours, in 22-35% of grade 2-3 tumours and in 35% of non-papillary tumours.

摘要

采用免疫细胞化学技术,对104例膀胱移行细胞肿瘤石蜡包埋活检标本(连续5微米切片)中c-erbB-2、p53和增殖细胞核抗原(PCNA)的表达进行了研究。104例肿瘤中46例(44%)c-erbB-2呈阳性,29例(28%)p53呈阳性,88例(85%)PCNA呈阳性。这些抗原的表达与T分期无关,而与组织学分化和乳头状状态显著相关,因此非乳头状高级别肿瘤通常所有抗原均呈阳性。104例病例中有8例(8%)c-erbB-2和p53表达强烈,76例(73%)表达较弱或无表达(p = 0.0003)。104例肿瘤中有22例(21%)p53和PCNA表达强烈,76例(73%)表达较弱或无表达(p = 0.0003)。c-erbB-2和PCNA的强烈表达也显著相关(p = 0.0202)。在T2-T4期肿瘤中,16%-29%的肿瘤同时表达这三种抗原;在2-3级肿瘤中,22%-35%的肿瘤同时表达这三种抗原;在非乳头状肿瘤中,35%的肿瘤同时表达这三种抗原。

相似文献

1
Interrelationship between expression of p53, proliferating cell nuclear antigen and c-erbB-2 in bladder cancer.膀胱癌中p53、增殖细胞核抗原与c-erbB-2表达之间的相互关系
Pathobiology. 1993;61(3-4):178-82. doi: 10.1159/000163788.
2
The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.p53、MDM2和c-erb B-2癌蛋白、表皮生长因子受体及增殖标志物在膀胱癌预后中的作用
Pathol Res Pract. 1997;193(11-12):767-75. doi: 10.1016/S0344-0338(97)80055-6.
3
Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.血吸虫病相关的、器官局限型、肌层浸润性膀胱癌:凋亡标志物、增殖标志物、p53、E-钙黏蛋白、表皮生长因子受体及c-erbB-2的预后价值
J Urol. 2001 May;165(5):1481-7.
4
Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma.
Histol Histopathol. 2000 Jul;15(3):721-7. doi: 10.14670/HH-15.721.
5
[Expression of PCNA/cyclin, p53, C-erbB-2 versus histological grade in transitional cell carcinoma of urinary bladder].[膀胱移行细胞癌中PCNA/细胞周期蛋白、p53、C-erbB-2的表达与组织学分级的关系]
Hinyokika Kiyo. 1995 Apr;41(4):253-8.
6
p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer.
Virchows Arch A Pathol Anat Histopathol. 1993;423(5):329-34. doi: 10.1007/BF01607144.
7
Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.膀胱癌中表皮生长因子受体的表达与既定预后因素、癌蛋白(c-erbB-2、p53)表达及长期预后的关系
Br J Cancer. 1994 Jun;69(6):1120-5. doi: 10.1038/bjc.1994.220.
8
Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.胃癌中p53蛋白、c-erbB-2蛋白、表皮生长因子受体蛋白及增殖细胞核抗原的免疫组织化学检测
J Korean Med Sci. 1993 Aug;8(4):293-304. doi: 10.3346/jkms.1993.8.4.293.
9
Immunohistochemical study of the proliferating ability and malignant potential of transitional cell carcinoma in the human urinary bladder.人膀胱移行细胞癌增殖能力和恶性潜能的免疫组织化学研究。
Int J Urol. 1996 Jan;3(1 Suppl):S32-4. doi: 10.1111/j.1442-2042.1996.tb00079.x.
10
PCNA and p53 in urinary bladder cancer: correlation with histological findings and prognosis.膀胱癌中的增殖细胞核抗原和p53:与组织学结果及预后的相关性
Int J Urol. 1997 Mar;4(2):172-7. doi: 10.1111/j.1442-2042.1997.tb00166.x.

引用本文的文献

1
Relationship of PCNA, C-erbB2 and CD44s expression with tumor grade and stage in urothelial carcinomas of the bladder.膀胱尿路上皮癌中PCNA、C-erbB2和CD44s表达与肿瘤分级和分期的关系
Int J Clin Exp Med. 2014 Jun 15;7(6):1516-23. eCollection 2014.
2
Confrontation of immunohistochemistry and fluorescent in situ hybridization for the assessment of HER-2/ neu (c-erbb-2) status in urothelial carcinoma.
Virchows Arch. 2004 May;444(5):415-9. doi: 10.1007/s00428-004-0986-4. Epub 2004 Mar 17.
3
Growth factors in bladder cancer.膀胱癌中的生长因子
World J Urol. 1995;13(6):349-55. doi: 10.1007/BF00191216.